Kala pharmaceuticals stock news
WebbAsset Growth. -37.73%. Trailing 12-Months. The Kala Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating … Webb12 apr. 2024 · April 12, 2024 - 8:00 am. ARLINGTON, Mass., April 12, 2024 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage …
Kala pharmaceuticals stock news
Did you know?
WebbKala Pharmaceuticals Inc (KALA) Stock Price Today, News, Quotes, FAQs and Fundamentals DIA 0.25% SPY 0.14% QQQ 0.16% CXAI ETH.X 7.29% LCID 5.82% … Webb15 mars 2024 · View the latest Kala Pharmaceuticals Inc. (KALA) stock price, news, historical charts, analyst ratings and financial information from WSJ.
WebbThe current KALA stock price $13.9 has increased 74.50% from its 52-week low Does KALA stock pay dividends? No, the KALA stock does not pay dividends to its shareholders What is KALA stock price target? The target price for KALA stock is $150 based on the average of what a group of analyst think KALA stock could be worth at a … WebbFind real-time KALA - Kala Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business.
Webb13 apr. 2024 · Latest Kala Pharmaceuticals Inc Stock News. As of April 06, 2024, Kala Pharmaceuticals Inc had a $27.8 million market capitalization, putting it in the 20th percentile of companies in the Pharmaceuticals industry. Kala Pharmaceuticals Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. Webb13 apr. 2024 · Kala Pharmaceuticals currently has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.. InflaRx Surges on EUA for Gohibic: InflaRx N.V.IFRX ...
Webb6 apr. 2024 · The reverse stock split will become effective at 4:05 p.m. on Thursday, October 20, 2024. Kala’s common stock will continue to be traded on the Nasdaq …
Webb11 apr. 2024 · In February 2024, Kala dosed the first patient in its CHASE (Corneal Healing After SEcretome therapy) Phase 2b trial evaluating KPI-012 for the treatment of … birmingham city football liveWebb4 jan. 2024 · View the latest Kala Pharmaceuticals Inc. (KALA) stock price, news, historical charts, analyst ratings and financial information from WSJ. birmingham city football club ticketsWebb6 apr. 2024 · NASDAQ:KALA Kala Pharmaceuticals - KALA News Today $15.05 +0.45 (+3.08%) (As of 03/31/2024 12:00 AM ET) Compare Today's Range $14.21 $15.10 50 … d and r power wagonWebb11 apr. 2024 · In February 2024, Kala dosed the first patient in its CHASE (Corneal Healing After SEcretome therapy) Phase 2b trial evaluating KPI-012 for the treatment of PCED. In March 2024, Kala announced positive safety data from the first cohort of two patients that were treated with a high dose of KPI-012 (3 U/mL) four times per day … birmingham city football club tickets onlineWebbFind the latest Kala Pharmaceuticals, Inc. (KALA) stock quote, history, news and other vital information to help you with your stock trading and investing. d and r sanitationWebb13 apr. 2024 · Kala Pharmaceuticals currently has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here . InflaRx Surges … birmingham city football fixtures 21/22Webb14 apr. 2024 · Kala Pharmaceuticals (NASDAQ:KALA – Get Rating) had its target price lifted by equities research analysts at HC Wainwright from $20.00 to $22.00 in a research note issued on Wednesday, The Fly reports.The brokerage currently has a “buy” rating on the stock. HC Wainwright’s price target suggests a potential upside of 23.32% from the … d and r small engine repair